Application of EPO in preparation of hepatocellular carcinoma TACE curative effect evaluation reagent
A technique for hepatocellular carcinoma and efficacy evaluation, applied in the field of biomedicine
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0016] The applicant's research found that the expression level of EPO in patient samples is directly correlated with the prognosis of TACE. If the level of EPO is high, the patient is not suitable for conventional TACE treatment; if the level of EPO is low, the prognosis of the patient is good with conventional TACE. Therefore, the present invention establishes a new TACE curative effect prediction system.
[0017] Hepatocellular carcinoma TACE curative effect evaluation reagents include EPO monoclonal antibody or polyclonal antibody, solid phase carrier coated with antibody and detection antibody capable of binding detectable signal molecules. A specific method can be as follows: add patient serum or plasma samples to the solid phase carrier coated with EPO monoclonal antibody or polyclonal antibody, after incubation, add biotinylated detection antibody (binding EPO), after incubation and washing, then Add horseradish peroxidase-labeled avidin, add TMB substrate to develop ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 

